Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea

American Journal of Tropical Medicine and Hygiene

Volumn 55, Issue 2, 1996, Pages 209-213

  Reeder, John C ^a   Rieckmann, Karl H ^b   Genton, Blaise ^c   Lorry, Kerry ^c   Wines, Brett ^b   Cowman, Alan F ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOGUANIL; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; PYRIMETHAMINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME STRUCTURE; GENE AMPLIFICATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALARIA; PAPUA NEW GUINEA; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; POINT MUTATION; PREDICTION;

PLASMODIUM FALCIPARUM;

EID: 0029775095     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.55.209     Document Type: Article

References (26)

1. Bzik DJ, Li W-B, Horii T, Inselburg J, 1987. Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. Proc Natl Acad Sci USA 84: 8360-8364.
2. Cowman AF, Morry MJ, Biggs BA, Cross GAM, Foote SJ, 1988. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 85: 9109-9113.
3. Peterson DS, Walliker D, Wellems TE, 1988. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci USA 85: 9114-9118.
4. Snewin VA, England SM, Sims PF, Hyde JE, 1989. Characterization of the dihydrofolate reductase-thymidylate synthetase gene from human malaria parasites highly resistant to pyrimethamine. Gene 76: 41-52.
5. Zolg JW, Plitt JR, Chen GX, Palmer S, 1989. Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum. Mol Biochem Parasitol 36: 253-262.
6. Sirawaraporn W, Sirawaraporn R, Cowman AF, Yuthavong Y, Santi DV, 1990. Heterologous expression of active thymidylate synthase-dihydrofolate reductase from Plasmodium falciparum. Biochemistry 29: 10779-10785.
7. Thaithong S, Chan SW, Songsomboon S, Wilairat P, Seesod N, Sueblinwong T, Goman M, Ridley R, Beale G, 1992. Pyrimethamine resistant mutations in Plusmodium falciparum. Mol Biochem Parasitol 52: 149-158.
8. Basco LK, de Pecoulas PE, Wilson CM, Le Bras J, Mazabraud A, 1995. Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol Biochem Parasitol 69: 135-138.
9. Foote SJ, Galatis D, Cowman AF, 1990. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc Natl Acad Sci USA 87: 3014-3017.
10. Peterson DS, Milhous WK, Wellems TE, 1990. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc Natl Acad Sci USA 87: 3018-3022.
11. Chulay JD, Watkins WM, Sixsmith DG, 1984. Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro. Am J Trop Med Hyg 33: 325-330.
12. Triglia T, Cowman AF, 1994. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 91: 7141-7153.
13. Brooks D, Wang P, Read M, Watkin W, Sims P, Hyde J, 1994. Sequence variation in the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem 224: 397-405.
14. Wang P, Brooks DR, Sims PFG, Hyde JE, 1995. A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthetase gene of Plasmodium falciparum. Mol Biochem Parasitol 75: 115-125.
15. Genton B, Al-Yaman F, Beck H-P, Hii J, Mellor S, Narara A, Gibson N, Smith T, Alpers MP, 1995. The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials I. Malariometric indices and immunity. Ann Trop Med Parasitol 89: 359-376.
16. Genton B, Al-Yaman F, Beck H-P, Hii J, Mellor S, Rare L, Ginny M, Smith T, Alpers MP, 1995. The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. II. Mortality and morbidity. Ann Trop Med Parasitol 89: 377-390.
17. Al-Yaman F, Genton B, Mokela D, Alpers MP, 1994. Resistance of Plasmodium falciparum in vivo to 3 days' treatment with quinine and single-dose Fansidar. P N G Med J 37: 54-56.
18. Genton B, Smith T, Baea K, Narara A, Al-Yaman F, Beck H-P, Hii J, Alpers M, 1994. Malaria: how useful are clinical criteria for improving the diagnosis in a highly endemic area? Trans R Soc Trop Med Hyg 88: 537-541.
19. Rieckmann KH, Sax LJ, Campbell GH, Mrema JE, 1978. Drug sensitivity of Plasmodium falciparum: an in vitro microtechnique. Lancet i: 22-23.
20. Eastham GN, Rieckman KH, 1983. The activity of pyrimethamine and sulphadoxine against Plasmodium falciparum determined by the in vitro microtechnique. Trans R Soc Trop Med Hyg 77: 91-93.
21. WHO, 1990. In Vivo Micro-Test (Mark H) for the Assessment of the Response of Plasmodium falciparum to Chloroquine, Mefloquine, Quinine, Sulfadoxine/Pyrimethamine and Amodiaquine. Geneva: World Health Organization, MAP/872 (Revision 1, June 1990).
22. Paabo S, 1990. Amplifying ancient DNA. Innis MA, Gelfand DH, Sninsky JJ, White TJ, eds. PCR Protocols. A Guide to Methods and Applications. San Diego: Academic Press, Inc., 159-166.
23. Basco LK, Ramiliarisoa O, Le Bras J, 1994. In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg 50: 193-199.
24. Peterson DS, Di SS, Povoa M, Calvosa VS, Do RV, Wellems TE, 1991. Prevalence of the dihydrofolate reductase Asn-108 mutation as the basis for pyrimethamine-resistant falciparum malaria in the Brazilian Amazon. Am J Trop Med Hyg 45: 492-497.
25. Tanaka M, Gu HM, Bzik DJ, Inselburg JW, 1990. Dihydrofolate reductase mutations and chromosomal changes associated with pyrimethamine resistance of Plasmodium falciparum. Mol Biochem Parasitol 39: 127-134.
26. Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE, 1995. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg 52: 565-568.